Published in J Immunol on January 15, 1997
Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Clin Microbiol Rev (2002) 2.67
Cryptosporidium pathogenicity and virulence. Clin Microbiol Rev (2013) 1.66
Update on the hyper immunoglobulin M syndromes. Br J Haematol (2010) 1.43
CD40 induces apoptosis in carcinoma cells through activation of cytotoxic ligands of the tumor necrosis factor superfamily. Mol Cell Biol (2000) 1.35
Requirement of CD40-CD40 ligand interaction for elimination of Cryptosporidium parvum from mice. Infect Immun (1998) 1.27
Primary antibody deficiencies. Nat Rev Immunol (2013) 1.20
The human immunodeficiency virus type 1 tat protein enhances Cryptosporidium parvum-induced apoptosis in cholangiocytes via a Fas ligand-dependent mechanism. Infect Immun (2006) 1.11
Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency. Clin Gastroenterol Hepatol (2013) 1.09
Hyper IgM syndrome presenting as chronic suppurative lung disease. Ital J Pediatr (2012) 1.07
Does the immune system naturally protect against cancer? Front Immunol (2014) 1.02
X-linked immunodeficiency with hyper-IgM (XHIM). Clin Exp Immunol (2000) 1.02
Defects of T-cell effector function and post-thymic maturation in X-linked hyper-IgM syndrome. J Clin Invest (1999) 1.02
Primary and malignant cholangiocytes undergo CD40 mediated Fas dependent apoptosis, but are insensitive to direct activation with exogenous Fas ligand. PLoS One (2010) 0.99
The molecular pathology of primary immunodeficiencies. J Mol Diagn (2004) 0.98
Immunodeficiencies. Clin Exp Immunol (2009) 0.96
Costimulation blockade: current perspectives and implications for therapy. Transplantation (2013) 0.95
Functional CD40 expression induced following bacterial infection of mouse and human osteoblasts. Infect Immun (2003) 0.94
CD40 induces anti-Toxoplasma gondii activity in nonhematopoietic cells dependent on autophagy proteins. Infect Immun (2013) 0.94
Klatskin-like lesions. HPB Surg (2012) 0.93
Intestinal immune response to human Cryptosporidium sp. infection. Infect Immun (2007) 0.93
C4b binding protein binds to CD154 preventing CD40 mediated cholangiocyte apoptosis: a novel link between complement and epithelial cell survival. PLoS One (2007) 0.92
HIV-1 Tat protein suppresses cholangiocyte toll-like receptor 4 expression and defense against Cryptosporidium parvum. J Infect Dis (2009) 0.91
Gastrointestinal and hepatic manifestations of primary immune deficiency diseases. Saudi J Gastroenterol (2010) 0.88
Osteopenia in X-linked hyper-IgM syndrome reveals a regulatory role for CD40 ligand in osteoclastogenesis. Proc Natl Acad Sci U S A (2007) 0.87
CD40 induces antigen transporter and immunoproteasome gene expression in carcinomas via the coordinated action of NF-kappaB and of NF-kappaB-mediated de novo synthesis of IRF-1. Mol Cell Biol (2008) 0.87
Eradication of Cryptosporidium parvum infection by mice with ovalbumin-specific T cells. Infect Immun (2000) 0.87
CD40-CD40 ligand interactions augment survival of normal mice, but not CD40 ligand knockout mice, challenged orally with Salmonella dublin. Infect Immun (1999) 0.86
The death domain kinase RIP1 links the immunoregulatory CD40 receptor to apoptotic signaling in carcinomas. J Cell Biol (2011) 0.85
Partial immune reconstitution of X-linked hyper IgM syndrome with recombinant CD40 ligand. Blood (2011) 0.84
Marrow-derived CD40-positive cells are required for mice to clear Cryptosporidium parvum infection. Infect Immun (2001) 0.83
Cryptosporidium parvum-specific CD4 Th1 cells from sensitized donors responding to both fractionated and recombinant antigenic proteins. Infect Immun (2004) 0.82
CD40 agonist antibody mediated improvement of chronic Cryptosporidium infection in patients with X-linked hyper IgM syndrome. Clin Immunol (2012) 0.81
Fulminant cryptosporidiosis after near-drowning: a human Cryptosporidium parvum strain implicated in invasive gastrointestinal adenocarcinoma and cholangiocarcinoma in an experimental model. Appl Environ Microbiol (2012) 0.81
CD40 and the immune response to parasitic infections. Semin Immunol (2009) 0.81
Three novel mutations reflect the variety of defects causing phenotypically diverse X-linked hyper-IgM syndrome. Clin Exp Immunol (2003) 0.81
Parasites and malignancies, a review, with emphasis on digestive cancer induced by Cryptosporidium parvum (Alveolata: Apicomplexa). Parasite (2012) 0.80
Immunogenetics: changing the face of immunodeficiency. J Clin Pathol (2000) 0.79
Requirement for TNF-Tnfrsf1 signalling for sclerosing cholangitis in mice chronically infected by Cryptosporidium parvum. Clin Exp Immunol (2002) 0.79
Clinical features and genetic analysis of 20 Chinese patients with X-linked hyper-IgM syndrome. J Immunol Res (2014) 0.79
Cholangiocarcinoma and high-grade dysplasia in young patients with primary sclerosing cholangitis. Dig Dis Sci (2014) 0.78
ICON: the early diagnosis of congenital immunodeficiencies. J Clin Immunol (2014) 0.77
X-linked hyper-IgM syndrome associated with poorly differentiated neuroendocrine tumor presenting as obstructive jaundice secondary to extensive adenopathy. Dig Dis Sci (2007) 0.76
Liver Abscesses and Hyper IgM Syndrome. J Family Med Prim Care (2013) 0.75
Cryptosporidium infection in solid organ transplantation. World J Transplant (2016) 0.75
Hyper IgM Syndrome: a Report from the USIDNET Registry. J Clin Immunol (2016) 0.75
Expression of CD40 and CD40L in gastric cancer tissue and its clinical significance. Int J Mol Sci (2009) 0.75
Cancers Related to Immunodeficiencies: Update and Perspectives. Front Immunol (2016) 0.75
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06
The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet (2001) 15.27
Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med (1999) 8.01
Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ (1995) 6.28
Childhood living conditions and Helicobacter pylori seropositivity in adult life. Lancet (1992) 6.28
Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol (1999) 5.98
Specific cloning of DNA fragments absent from the DNA of a male patient with an X chromosome deletion. Proc Natl Acad Sci U S A (1985) 5.50
TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature (2001) 5.24
An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin 1, and tumor necrosis factor-alpha increases neutrophil adherence by a CDw18-dependent mechanism. J Immunol (1986) 5.14
IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2. Proc Natl Acad Sci U S A (1988) 5.03
Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat Immunol (2000) 5.01
The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature (1998) 4.47
End-of-life decisions in medical practice in Flanders, Belgium: a nationwide survey. Lancet (2000) 4.39
Porphyromonas gingivalis invasion of gingival epithelial cells. Infect Immun (1995) 4.33
Room-temperature ferroelectricity in strained SrTiO3. Nature (2004) 4.18
CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM. Nature (1993) 4.11
Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell (1994) 4.04
Minor Xp21 chromosome deletion in a male associated with expression of Duchenne muscular dystrophy, chronic granulomatous disease, retinitis pigmentosa, and McLeod syndrome. Am J Hum Genet (1985) 3.83
Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr (1997) 3.63
Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells. J Virol (1998) 3.54
The role of neutrophil membrane glycoprotein GP-150 in neutrophil adherence to endothelium in vitro. Blood (1985) 3.53
Salivary antibodies to Helicobacter pylori: screening dyspeptic patients before endoscopy. Lancet (1994) 3.45
BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J Exp Med (2001) 3.40
Human recombinant interleukin 4 induces Fc epsilon receptors (CD23) on normal human B lymphocytes. J Exp Med (1987) 3.22
Partial V(D)J recombination activity leads to Omenn syndrome. Cell (1998) 3.18
Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J (1994) 3.13
Human lymphocyte subpopulations. Effect of corticosteroids. J Clin Invest (1974) 2.96
Isolation of AIDS virus from cell-free breast milk of three healthy virus carriers. Lancet (1985) 2.77
Community-based follow-up for late patients enrolled in a district-wide programme for antiretroviral therapy in Lusaka, Zambia. AIDS Care (2008) 2.73
Cbl associates with Pyk2 and Src to regulate Src kinase activity, alpha(v)beta(3) integrin-mediated signaling, cell adhesion, and osteoclast motility. J Cell Biol (2001) 2.69
Integrated plasma cortisol concentration in children with asthma receiving long-term inhaled corticosteroids. Pediatr Pulmonol (1992) 2.68
Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet (1999) 2.63
Induction of erythroid differentiation in murine virus infected eythroleukemia cells by highly polar compounds. Proc Natl Acad Sci U S A (1975) 2.60
CD21 is a ligand for CD23 and regulates IgE production. Nature (1992) 2.58
CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. J Clin Invest (1999) 2.58
Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci U S A (1997) 2.56
Inducible expression of human beta-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier. Infect Immun (2000) 2.55
Fluctuations in symptoms in human immunodeficiency virus-infected children: the first 10 years of life. Pediatrics (2001) 2.54
Nanoscale control of an interfacial metal-insulator transition at room temperature. Nat Mater (2008) 2.47
Detection of virus in vertically exposed HIV-antibody-negative children. Lancet (1996) 2.38
Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation. EMBO J (1998) 2.36
Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens. Antimicrob Agents Chemother (1985) 2.36
Glycemic control in gestational diabetes mellitus--how tight is tight enough: small for gestational age versus large for gestational age? Am J Obstet Gynecol (1989) 2.31
Immune response after splenectomy. Lancet (1978) 2.31
Atypical herpes simplex virus encephalitis diagnosed by PCR amplification of viral DNA from CSF. Neurology (1998) 2.26
Evidence for autosomal recessive inheritance in cerebral gigantism. J Med Genet (1974) 2.26
Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine. J Infect Dis (2008) 2.25
Interleukin 5 enhances interleukin 4-induced IgE production by normal human B cells. The role of soluble CD23 antigen. Eur J Immunol (1988) 2.20
Transforming growth factor-beta and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype. J Immunol (1991) 2.15
Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation (1997) 2.12
Induction of erythroid differentiation by dimethylsulfoxide in cells infected with Friend virus: relationship to the cell cycle. Proc Natl Acad Sci U S A (1975) 2.12
Monoclonal antibody-defined functional epitopes on the adhesion-promoting glycoprotein complex (CDw18) of human neutrophils. Blood (1986) 2.07
Human native soluble CD40L is a biologically active trimer, processed inside microsomes. J Biol Chem (1996) 2.06
Severe recurrent bacterial infections associated with defective adherence and chemotaxis in two patients with neutrophils deficient in a cell-associated glycoprotein. J Pediatr (1982) 2.03
Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration. Nat Genet (1995) 2.03
Production and characterization of a monoclonal antibody specific for the human lymphocyte low affinity receptor for IgE: CD 23 is a low affinity receptor for IgE. J Immunol (1987) 1.99
Gastrointestinal manifestations of chronic granulomatous disease. N Engl J Med (1973) 1.99
IgE versus IgG4 production can be differentially regulated by IL-10. J Immunol (1998) 1.98
Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction. Proc Natl Acad Sci U S A (1991) 1.95
CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency. Proc Natl Acad Sci U S A (1994) 1.94
Characterization and description of "Campylobacter upsaliensis" isolated from human feces. J Clin Microbiol (1990) 1.93
The future of scattered trees in agricultural landscapes. Conserv Biol (2008) 1.92
Inoculation of baboons and macaques with simian immunodeficiency virus/Mne, a primate lentivirus closely related to human immunodeficiency virus type 2. J Virol (1988) 1.91
The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets. Blood (1980) 1.91
Characterization of exogenous type D retrovirus from a fibroma of a macaque with simian AIDS and fibromatosis. Science (1984) 1.89
Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome. Blood (1998) 1.89
IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena. Curr Opin Pediatr (2001) 1.87
Studies of the expression of the Wiskott-Aldrich syndrome protein. J Clin Invest (1996) 1.87
The new syndrome of congenital hypoparathyroidism associated with dysmorphism, growth retardation, and developmental delay--a report of six patients. Isr J Med Sci (1995) 1.86
Expression of the peptide antibiotic human beta-defensin 1 in cultured gingival epithelial cells and gingival tissue. Infect Immun (1998) 1.86
Enterococcal bacteremia without endocarditis. Arch Intern Med (1981) 1.85
Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum. Am Rev Respir Dis (1985) 1.85
Fatal injection sclerotherapy of a bleeding peptic ulcer. Lancet (1991) 1.84
A permeability barrier as a mechanism of chloramphenicol resistance in Haemophilus influenzae. Antimicrob Agents Chemother (1985) 1.84
Muscle disease in progressive systemic sclerosis: diagnostic and therapeutic considerations. Arthritis Rheum (1978) 1.83
Recombinant 25-kDa CD23 and interleukin 1 alpha promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis. Eur J Immunol (1991) 1.82
Physical and functional association of LFA-1 with DNAM-1 adhesion molecule. Immunity (1999) 1.79
Congenital insensitivity to pain with anhidrosis (CIPA) in Israeli-Bedouins: genetic heterogeneity, novel mutations in the TRKA/NGF receptor gene, clinical findings, and results of nerve conduction studies. Am J Med Genet (2000) 1.79
CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex. Nat Neurosci (2000) 1.78
Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype. Blood (1997) 1.77
Community-acquired bacteremia among hospitalized children in rural central Africa. Int J Infect Dis (2001) 1.76
Immunologic responses to bacteriophage phi-X 174 in immunodeficiency diseases. J Clin Invest (1971) 1.76
Regional nodal management and patterns of failure following conservative surgery and radiation therapy for stage I and II breast cancer. Int J Radiat Oncol Biol Phys (1993) 1.74
A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA-->AAUGAA) leads to the IPEX syndrome. Immunogenetics (2001) 1.72
Regulation of Fc receptor for IgE (CD23) and class II MHC antigen expression on Burkitt's lymphoma cell lines by human IL-4 and IFN-gamma. J Immunol (1988) 1.67
Shipment impairs lymphocyte proliferative responses to microbial antigens. Clin Diagn Lab Immunol (2000) 1.67
A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells. Eur J Immunol (1999) 1.66
Detection of 4-quinolone resistance mutation in gyrA gene of Shigella dysenteriae type 1 by PCR. Antimicrob Agents Chemother (1994) 1.66
Mammographically detected breast cancer. Benefits of stereotactic core versus wire localization biopsy. Ann Surg (1996) 1.66
Retroperitoneal fibromatosis and acquired immunodeficiency syndrome in macaques. Pathologic observations and transmission studies. Am J Pathol (1985) 1.65
Absence of monoclonal-antibody-defined protein complex in boy with abnormal leucocyte function. Lancet (1984) 1.63
Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiency. Nat Genet (2001) 1.62
Anticoagulation monitoring during cardiac surgery: a review of current and emerging techniques. Anesthesiology (1999) 1.62
Defective humoral immunity in pediatric acquired immune deficiency syndrome. J Pediatr (1985) 1.61
Effects of a medical team coordinator on length of hospital stay. CMAJ (1992) 1.61
Community-acquired bacteraemia in African children. Lancet (1987) 1.61
Identification of surface proteins mediating adherence of CD11/CD18-deficient lymphoblastoid cells to cultured human endothelium. J Clin Invest (1990) 1.61
Skin hyperreactivity response (pathergy) in Behçet's disease. J Am Acad Dermatol (1989) 1.60